Menopause Hormone Therapy (HRT) in Frisco, TX

Bioidentical hormones in Frisco: what it means

"Bioidentical" describes a hormone whose chemical structure matches one the body makes. Two hormones used in menopause care fit it exactly, estradiol and micronized progesterone. Both come in FDA-approved prescription forms, from estradiol pills, patches, gels and vaginal forms to progesterone capsules.

Compounded hormones are a different thing: a pharmacy prepares them for one patient, as a cream, a capsule or a pellet. Compounded drugs are not FDA-approved, so the FDA cannot assure their safety, effectiveness or dose. The FDA says it has no evidence that compounded "bioidentical hormones" are safe and effective, or more effective than FDA-approved hormone therapy. The National Academies, reviewing them for the FDA in 2020, called their wide use a public health concern.

Through VevaMD, a physician licensed in Texas decides whether hormone therapy fits you and, if so, the form: an estradiol pill, patch, cream or vaginal cream, with progesterone if you have a uterus. Pellets are not part of it. Since the pharmacy that fills these prescriptions also compounds, ask whether yours is an FDA-approved product or compounded. Two options are compounded for certain: testosterone cream for women and Bi-Est are not FDA-approved.

For its size, Frisco is well supplied with OB-GYNs: the NPI registry lists 77, or 36.6 per 100,000 residents, against 17.8 for the US and above Texas's 15.4. That is about 360 women aged 45 to 64 for each OB-GYN in the city, a ratio rather than a count of open appointments.

Widen the circle and the count grows: 175 in the city or within 10 miles, 737 within 25 miles. For the 3,371,349 people who live within 25 miles, that is 21.9 per 100,000. Whether or not you have an OB-GYN, you can ask a physician licensed in Texas about menopause hormone therapy online from Frisco, with no waiting room.

Then there are pellets, implanted under the skin at a clinic; compounded pellets are not FDA-approved. The Endocrine Society points to a study that found hormone levels well above the expected range in women using them. ACOG advises FDA-approved hormone therapy over compounded preparations.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11